As Israel’s Foamix prepares to go public, enter Phase III trials and get FDA approval, the latest results of its acne treatment are impressive; 72% reduction in pimples for 150 patients with moderate to severe acne during the 12-week treatment period; and zero side effects.
http://www.timesofisrael.com/israeli-firms-novel-acne-treatment-foams-up-to-ipo/